Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases., PMID:40228767
Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases., PMID:40228767
CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors., PMID:39805660
CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors., PMID:39805660
Immuno-PET Imaging of CD93 Expression with 64Cu-Radiolabeled NOTA-mCD93 ([64Cu]Cu-NOTA-mCD93) and Insulin-Like Growth Factor Binding Protein 7 ([64Cu]Cu-NOTA-IGFBP7)., PMID:39533706
Immuno-PET Imaging of CD93 Expression with 64Cu-Radiolabeled NOTA-mCD93 ([64Cu]Cu-NOTA-mCD93) and Insulin-Like Growth Factor Binding Protein 7 ([64Cu]Cu-NOTA-IGFBP7)., PMID:39533706
Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity., PMID:38896451
Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity., PMID:38896451
Screening and construction of nanobodies against human CD93 using phage libraries and study of their antiangiogenic effects., PMID:38751868
Screening and construction of nanobodies against human CD93 using phage libraries and study of their antiangiogenic effects., PMID:38751868
Unveiling the role of IL-17: Therapeutic insights and cardiovascular implications., PMID:38735805
Unveiling the role of IL-17: Therapeutic insights and cardiovascular implications., PMID:38735805
CD93 maintains endothelial barrier function and limits metastatic dissemination., PMID:38441970
Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses., PMID:38250037
Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses., PMID:38250037
Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespan., PMID:37164016
Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespan., PMID:37164016
Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity., PMID:36891288
Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity., PMID:36891288
CD93 promotes acute myeloid leukemia development and is a potential therapeutic target., PMID:36152731
CD93 promotes acute myeloid leukemia development and is a potential therapeutic target., PMID:36152731
CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance., PMID:36006582
CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance., PMID:36006582
Single-cell transcriptome profiling and the use of AID deficient mice reveal that B cell activation combined with antibody class switch recombination and somatic hypermutation do not benefit the control of experimental trypanosomosis., PMID:34762705
Single-cell transcriptome profiling and the use of AID deficient mice reveal that B cell activation combined with antibody class switch recombination and somatic hypermutation do not benefit the control of experimental trypanosomosis., PMID:34762705
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy., PMID:34321321
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy., PMID:34321321
CD93 has a crucial role in pathogenesis of psoriasis., PMID:34028163
CD93 has a crucial role in pathogenesis of psoriasis., PMID:34028163
Characterization of the Cell Surface Phenotype and Regulatory Activity of B-Cell IgD Low (BDL) Regulatory B Cells., PMID:33479901
Characterization of the Cell Surface Phenotype and Regulatory Activity of B-Cell IgD Low (BDL) Regulatory B Cells., PMID:33479901
miR-148a controls metabolic programming and survival of mature CD19-negative plasma cells in mice., PMID:33336366
miR-148a controls metabolic programming and survival of mature CD19-negative plasma cells in mice., PMID:33336366
Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML., PMID:33085758
Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML., PMID:33085758
The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization., PMID:32697305
The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization., PMID:32697305
Tracing Self-Reactive B Cells in Normal Mice., PMID:32414809
Tracing Self-Reactive B Cells in Normal Mice., PMID:32414809
Radioimmunoimaging of 125I-labeled anti-CD93 monoclonal antibodies in a xenograft model of non-small cell lung cancer., PMID:31819775
Radioimmunoimaging of 125I-labeled anti-CD93 monoclonal antibodies in a xenograft model of non-small cell lung cancer., PMID:31819775
The hepatic effects in dams that ingested 2-aminoanthracene during gestation and lactation., PMID:31558114
The hepatic effects in dams that ingested 2-aminoanthracene during gestation and lactation., PMID:31558114
Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double-blind, placebo-controlled study., PMID:29974963
Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double-blind, placebo-controlled study., PMID:29974963
CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis., PMID:29923617
CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis., PMID:29923617
Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis., PMID:28962592
Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis., PMID:28962592
Generation of precursor, immature, and mature murine B1-cell lines from c-myc/bcl-xL-overexpressing pre-BI cells., PMID:28294314
Generation of precursor, immature, and mature murine B1-cell lines from c-myc/bcl-xL-overexpressing pre-BI cells., PMID:28294314
CD93 as a Potential Target in Neovascular Age-Related Macular Degeneration., PMID:27859225
CD93 as a Potential Target in Neovascular Age-Related Macular Degeneration., PMID:27859225
Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination., PMID:27529750
Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination., PMID:27529750
B-1 B cell progenitors transiently and partially express keratin 5 during differentiation in bone marrow., PMID:26655443
B-1 B cell progenitors transiently and partially express keratin 5 during differentiation in bone marrow., PMID:26655443
B-1a transitional cells are phenotypically distinct and are lacking in mice deficient in IκBNS., PMID:25228759
B-1a transitional cells are phenotypically distinct and are lacking in mice deficient in IκBNS., PMID:25228759
The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target., PMID:24809468
The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target., PMID:24809468
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q., PMID:24807719
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q., PMID:24807719
Soluble CD93 levels in patients with acute myocardial infarction and its implication on clinical outcome., PMID:24801400
Soluble CD93 levels in patients with acute myocardial infarction and its implication on clinical outcome., PMID:24801400
BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice., PMID:23560095
BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice., PMID:23560095
The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response., PMID:23201921
The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response., PMID:23201921
BAFF-R expression correlates with positive selection of immature B cells., PMID:22028296
BAFF-R expression correlates with positive selection of immature B cells., PMID:22028296
Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood., PMID:20512406
Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood., PMID:20512406
C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets., PMID:20163886
C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets., PMID:20163886
Old mice retain bone marrow B1 progenitors, but lose B2 precursors, and exhibit altered immature B cell phenotype and light chain usage., PMID:19428460
CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche., PMID:19228948
CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche., PMID:19228948
CD93 and related family members: their role in innate immunity., PMID:18288964
CD93 and related family members: their role in innate immunity., PMID:18288964
Differentiation and Ig-allele switch in cell line WEHI-231., PMID:17982026
Differentiation and Ig-allele switch in cell line WEHI-231., PMID:17982026
Regulation of CD93 cell surface expression by protein kinase C isoenzymes., PMID:16490927
Regulation of CD93 cell surface expression by protein kinase C isoenzymes., PMID:16490927
CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma., PMID:16002728
CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma., PMID:16002728
Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors., PMID:15624764
Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors., PMID:15624764
Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis., PMID:15004139
Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis., PMID:15004139
Human cord blood leukocyte innate immune responses to defense collagens., PMID:12904598
Human cord blood leukocyte innate immune responses to defense collagens., PMID:12904598
Structure-function studies of the receptors for complement C1q., PMID:12440963
Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q., PMID:11994479
Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q., PMID:11994479
For research use only. Not for human or drug use.
